Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News February 12th 2010

February 12th 2010

Diabetic foot problems – inpatient management
Draft scope for consultation: 9 February to 5pm on 9 March 2010 (NICE)

Fulbright Diabetes UK Research Award.
Applications for this Award opened on 1 February and close 31 May 2010 (Fulbright Commission)

Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes
Closed-loop systems could reduce risk of nocturnal hypoglycaemia in children and adolescents with type 1 diabetes (The Lancet)

More young diabetics in Wales need sight-saving action
Surgeons in Wales are having to give sight-saving treatment to patients in their late teens and 20s struggling to control their diabetes (BBC, UK)

More than 3,000 emergency hospital admissions a year for children with diabetes
Latest figures reveal that last year there were more than 3,300 cases of children in England admitted to accident and emergency departments with .Diabetic ketoacidosis (DiabeteUK)

Hemoglobin A1c is a reliable criterion for diagnosing type 1 diabetes in childhood and adolescence
Childhood type 1 diabetes can be diagnosed and excluded with high reliability by means of HbA1c testing (Pediatric Diabetes)

New hope for diabetics
Innovative treatment begins clinical trials at (McGill University Health Centre, Canada)

Diabetes Care Gaps and Disparities in Canada
This report examines the extent to which people with diabetes received recommended care to prevent complications and the disparities in receiving this care (Canadian Institute for Health Information)

Are Children the Future of Type 2 Diabetes Prevention?
The lifetime risk of type 2 diabetes is now more than one in three in the general U.S. population, and one in six adolescents is now obese, suggesting that prevention should start in childhood (NEJM)

Norwegian University Develops Self Help System To Monitor Diabetes Patients
A PhD project at the NST has resulted in the development of a new self-help system for diabetes, based on a mobile telephone, blood glucose meter, and step counter (eGov Monitor)

A disparity between physician attitudes and practice regarding hyperglycemia in pediatric intensive care units in the United States
Considerable disparity exists between physician beliefs and actual practice habits regarding glycemic control among pediatric practitioners, with few centers reporting the use of any consistent standard approach to screening and management (Critical Care)

Hypomagnesaemia is associated with diabetes: Not pre-diabetes, obesity or the metabolic syndrome
Diabetes is associated with hypomagnesaemia, but not its pre-cursor states (Diabetes Research and Clinical Practice)

Roche Diabetes Candidate Meets Goals of Five Trials (Update1)
Clinical trials show that its experimental diabetes drug taspoglutide reduced blood sugar levels when compared with or added to widely prescribed treatments (BusinesWeek)

Teplizumab therapy for type 1 diabetes
In Phase I/II randomized control trials, in patients with new onset T1D, teplizumab slowed the rate of loss of ß-cell function over 2 years of follow-up (Expert Opinion on Biological Therapy)

Drug Induced Diabetes – Understanding Which CV Drugs are Involved
Because overweight and obese individuals are often at increased risk for diabetes, and commonly treated for hypertensive and lipid disorders, care should be taken to select a medication regimen to treat the disorders while sparing the effects on insulin resistance (Cardiosource)

Categories: News Pre-2012

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Platinum Sponsors

Boehringer Ingelheim Lilly

Gold Sponsors

Novo NordiskAstraZenecaNapp DiabetesSanofi Diabetes

Silver Sponsors

AmgenWelsh Endocrinology and Diabetes Society (WEDS)Abbott Diabetes Care

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2021 Glycosmedia Partnership